Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
05/2005
05/19/2005WO2005045413A1 A method of reducing interferences in an electrochemical sensor using two different applied potentials
05/19/2005WO2005045412A1 Method of reducing the effect of direct interference current in an electrochemical test strip
05/19/2005WO2005045410A1 Differential compensated vapor sensor
05/19/2005WO2005045408A1 Lateral flow immunoassay device
05/19/2005WO2005045406A1 Inspection device for objects with a spherical surface
05/19/2005WO2005045397A1 Agricultural product handling system
05/19/2005WO2005045396A2 Use of particulate labels in bionalyte detection methods
05/19/2005WO2005045395A2 Method of detecting bovine spongiform encephalopathy
05/19/2005WO2005045392A2 Detection and identification of biopolymers using fluorescence quenching
05/19/2005WO2005045205A2 Combinatorial lubricating oil composition libraries
05/19/2005WO2005045075A2 Sample preparation methods and devices
05/19/2005WO2005045067A1 Improvements relating to semen preservation
05/19/2005WO2005045066A1 Folate antagonists having improved selectivity
05/19/2005WO2005045064A1 Screening method with the use of tbk1 knockout mouse
05/19/2005WO2005045063A1 Method for estimating damage of cell and tissue and measuring device therefor
05/19/2005WO2005045058A2 Detecting human anti-therapeutic antibodies
05/19/2005WO2005045057A2 Methods for diagnosing bipolar and unipolar disorder
05/19/2005WO2005045056A2 Radioactive multiplexing analytical methods
05/19/2005WO2005045028A1 Cell-free notch cleavage analysis method and drug screening method
05/19/2005WO2005044997A2 Identification of novel targets for radio sensitization using a genomic-based radiation sensitivity classifier
05/19/2005WO2005044992A2 Fusion initiation region in rna virus envelope proteins
05/19/2005WO2005044989A2 Polynucleotides and polypeptides of anaplasma phagocytophilum and methods of using the same
05/19/2005WO2005044974A2 Cell death-related nucleases and their uses
05/19/2005WO2005044963A2 High throughput screening methods for lubricating oil compositions
05/19/2005WO2005044962A2 High througput preparation of lubricating oil compositions for combinatorial libraries
05/19/2005WO2005044961A2 High throughput screening methods for lubricating oil compositions
05/19/2005WO2005044923A1 Cyanine dye labelling reagents
05/19/2005WO2005044861A1 Polysaccharides of helicobacter pylori
05/19/2005WO2005044860A1 Apparatus and method for processing meal and water to batter for recovering starch and/or protein therefrom, and batter produced with this apparatus and/or method
05/19/2005WO2005044847A1 Marker peptide for alzheimer’s disease
05/19/2005WO2005044846A1 Adrenomedullin 2 and use thereof
05/19/2005WO2005044843A1 Regulation of cell division and plant nodulation
05/19/2005WO2005044840A2 Modulation of anergy and methods for isolating anergy-modulating compounds
05/19/2005WO2005044838A2 Cd4+ epitopes of bone morphogenetic proteins
05/19/2005WO2005044794A2 Immunohistochemical methods
05/19/2005WO2005044792A2 Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
05/19/2005WO2005044429A2 Reagent-containing membranes and laminates and methods of their prepration
05/19/2005WO2005044301A2 Use of specific histones for the treatment of parasitic diseases
05/19/2005WO2005044293A2 Compositions able to prevent neurodegenerative processes and methods of assaying the same
05/19/2005WO2005044292A2 Biomarkers of resistance to hiv-infections in humans and biological applications thereof
05/19/2005WO2005044244A2 Use of mrp4-inhibitors for the treatment and/or prophylaxis of cardiovascular diseases
05/19/2005WO2005044100A1 Semipermeable sensors for detecting analyte
05/19/2005WO2005044091A2 Diagnostic and therapeutic methods and compositions involving pten and breast cancer
05/19/2005WO2005044077A2 Assay for acetyltransferases and acetyltransferase substrates
05/19/2005WO2005043992A1 Attention-deficient hyperactivity disorder (adhd) model mouse
05/19/2005WO2005043973A2 Assay systems and methods for detecting molecules that interact with sk2 channels
05/19/2005WO2005038596A9 Method and apparatus for estimation of the electrostatic affinity between molecules using a basis expansion
05/19/2005WO2005033326A3 Method of extending single-stranded nucleic acid, single-stranded nucleic acid extending apparatus and dna chip
05/19/2005WO2005024378A3 Ion detection using a pillar chip
05/19/2005WO2005023855A3 K203 gene and protein
05/19/2005WO2005022160A3 Diagnosis and treatment of micobacterial infections
05/19/2005WO2005022113A3 Ion channel assay methods
05/19/2005WO2005021801A3 Pathogenic gene for coronary artery disease
05/19/2005WO2005021713A8 Vectors expressing sars immunogens, compositions containing such vectors or expression products thereof, methods and assays for making and using
05/19/2005WO2005017692A9 An advanced databasing system for chemical, molecular and cellular biology
05/19/2005WO2005017646A3 System, software and methods for biomarker identification
05/19/2005WO2005017093A8 Polypeptides of streptococcus pyogenes
05/19/2005WO2005015158A9 T1r hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds
05/19/2005WO2005014635A3 Secreted polypeptide species reduced in cardiovascular disorders
05/19/2005WO2005012361A3 Antibodies raised against colon carcinomas
05/19/2005WO2005005956A3 Fluorophore compounds and their use in biological systems
05/19/2005WO2005005955A3 Specific detection of chitin using chitin-binding domain
05/19/2005WO2005003786A3 Human g protein-coupled receptor and modulators thereof for the treatment of cardiovascular disorders
05/19/2005WO2004110367A3 Sdr proteins from staphylococcus capitis and their use in preventing and treating infections
05/19/2005WO2004106934A3 Diagnostics and therapeutics for diseases associated with 5-hydroxytryptamine (serotonin) receptor 7 (5-ht7)
05/19/2005WO2004097406A3 Nϵ AND/OR Nα DERIVATIZED, METAL AND ORGANIC PROTECTED L-HISTIDINE FOR COUPLING TO BIOMOLECULES FOR HIGHLY EFFICIENT LABELING WITH [M(OH2)3(CO)3]+ BY FAC COORDINATION
05/19/2005WO2004087505A3 Dual-opening sample containers, fluid sampling device and method of using same
05/19/2005WO2004069751A3 Apparatus and method of portable automated biomonitoring of water quality
05/19/2005WO2004062472A3 System and method for in vitro bleeding time testing
05/19/2005WO2004061121A3 Method and apparatus for following cells
05/19/2005WO2004048539A3 Mapcaxs as modifiers of the apc and axin pathways and methods of use
05/19/2005WO2004045495A3 Interacting site for gp41 on gp120 of hiv-1
05/19/2005WO2004039244A3 Methods and kits for diagnosing tumorigenicity
05/19/2005WO2004025258A3 Gene segregation and biological sample classification methods
05/19/2005WO2004017356A8 Process and apparatus for pulsed dc magnetron reactive sputtering of thin film coatings on large substrates using smaller sputter cathodes
05/19/2005WO2004016726A3 Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms
05/19/2005WO2003106492A8 Marker for stem cells and its use
05/19/2005WO2003097792A3 Polypeptide immobilization
05/19/2005WO2003093786A3 Short enzyme donor fragment
05/19/2005WO2003065873A3 Sga-1m, a cancer associated antigen, and uses thereof
05/19/2005WO2003014703A3 Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof
05/19/2005WO2003009815A3 Compositions and methods for modulating blood-brain barrier transport
05/19/2005WO2002086062A9 Methods of screening for compounds that modulate hormone receptor activity
05/19/2005US20050107973 Synthetic gas reactor system with gas or liquid injection
05/19/2005US20050107961 Apparatus for managing gene expression data
05/19/2005US20050107960 Describing and storing method of alignment information
05/19/2005US20050107957 Method of visualizing non-targeted metabolomic data generated from fourier transform ion cyclotron resonance mass spectrometers
05/19/2005US20050107617 Mobility-modifying cyanine dyes
05/19/2005US20050107615 Immobilization of compounds with connector groups of amines
05/19/2005US20050107597 Nucleotide sequences coding microorganismal secondary response gene (SPA-1) for as tool in diagnosis, prevention and treatment of pseudomonal infection
05/19/2005US20050107592 Lipid binding protein 1
05/19/2005US20050107589 Membrane fusion protein for use as toole in the treatment and prevention of inflammatory bowel and autoimmune diseases
05/19/2005US20050107528 Element for protein microarrays
05/19/2005US20050107441 screening for drugs that alter glucose production by modulating gene expression and/or activity of the nuclear receptor short heterodimer partners, then using the drugs as hypoglycemic or hyperglycemic agents; antidiabetic agents; metabolic disorders
05/19/2005US20050107321 FLK-1 is a receptor for vascular endothelial growth factor
05/19/2005US20050107314 Modulation of cd200 receptors
05/19/2005US20050107293 Protein modification and maintenance polypeptides (PMOD) for use as diagnostic and therapeutic tools in treatment of prevention of gastrointestinal, cardiovascular, autoimmune/inflammatory, cell proliferative, developmental, epithelial, neurological, and reproductive disorders
05/19/2005US20050107285 comprising an agent which inhibits Fc gamma RIIIb receptor activity, activation or expression; Rheumatoid Arthritis
05/19/2005US20050106758 Biosensor, magnetic molecule measurement method, and measurement object measuring method
05/19/2005US20050106757 Bioassay for detection of preferential antibodies in solution; immunoaffinity chromatography
1 ... 2116 2117 2118 2119 2120 2121 2122 2123 2124 2125 2126 2127 2128 2129 2130 2131 2132 2133 2134 2135 2136 ... 3937